Lessee, Operating Lease, Liability, to be Paid in USD of Freeline Therapeutics Holdings plc from Q1 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Freeline Therapeutics Holdings plc quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q1 2022 to Q3 2023.
  • Freeline Therapeutics Holdings plc Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2023 was $4.34M, a 74.2% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Freeline Therapeutics Holdings plc Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $4.34M -$12.5M -74.2% 30 Sep 2023 6-K 01 Dec 2023
Q2 2023 $5.26M -$66.4M -92.7% 30 Jun 2023 6-K 15 Aug 2023
Q1 2023 $5.92M -$74.3M -92.6% 31 Mar 2023 6-K 30 May 2023
Q4 2022 $20.3M 31 Dec 2022 20-F 04 Apr 2023
Q3 2022 $16.8M 30 Sep 2022 6-K 15 Nov 2022
Q2 2022 $71.6M 30 Jun 2022 6-K 09 Aug 2022
Q1 2022 $80.2M 31 Mar 2022 6-K 10 May 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.